Vasomune Therapeutics, Inc. is a private early stage biopharmaceutical company developing the next generation of medicines to harness the body’s ability to defend against illness. The company is transitioning in the near term to the clinic with a novel therapeutic approach to COVID-19 that involves targeting a signaling molecule in the vasculature responsible for regulating barrier defense and promoting endothelial stability...
Vasomune Therapeutics, Inc. is a private early stage biopharmaceutical company developing the next generation of medicines to harness the body’s ability to defend against illness. The company is transitioning in the near term to the clinic with a novel therapeutic approach to COVID-19 that involves targeting a signaling molecule in the vasculature responsible for regulating barrier defense and promoting endothelial stability.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.